Correspondence to Paul Blazey, Center for Hip Health and Mobility, The University of British Columbia, Vancouver V5Z 1M9, British Columbia, Canada; paul.blazey{at}ubc.ca The International Olympic ...
Vosoritide, a precision pharmacological treatment, was approved for use in patients with achondroplasia in 2021. This Consensus Statement brings together an international group of experts to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results